Physician profile
Robert E Parke
NPI 1962470161
$7,877.85
in general payments reported to CMS, 2019-2025
34 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,448 · 2020: $1,119 · 2021: $767 · 2022: $544.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $1,589.82 | 2019-2022 | |
| Astrazeneca Pharmaceuticals Lp | $1,165.41 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $743.24 | 2019-2021 | |
| Glaxosmithkline, LLC. | $732.21 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $542.40 | 2019-2022 | |
| Insmed, INC. | $457.45 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $360.82 | 2019-2020 | |
| Sanofi Pasteur INC. | $274.15 | 2019-2020 | |
| Amarin Pharma, INC. | $273.78 | 2019-2021 | |
| Genentech USA, INC. | $263.74 | 2019 | |
| Novo Nordisk INC | $204.85 | 2019-2020 | |
| Mylan Specialty L.P. | $199.85 | 2019-2022 | |
| Philips North America LLC | $168.50 | 2019-2020 | |
| Intersect Ent, INC. | $115.31 | 2019 | |
| Allergan, INC. | $94.03 | 2019-2020 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shire North American Group INC | $90.62 | 2019 | |
| Novartis Pharmaceuticals Corporation | $77.28 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $68.43 | 2019-2020 | |
| Advanced Respiratory, INC | $65.19 | 2020 | |
| Merck Sharp & Dohme LLC | $53.41 | 2019 | |
| Aytu Biopharma, INC. | $52.55 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $42.29 | 2019 | |
| Abbvie INC. | $36.66 | 2019-2020 | |
| Arbor Pharmaceuticals, INC. | $30.20 | 2019 | |
| Lilly USA, LLC | $29.34 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $24.07 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $23.30 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $18.66 | 2021 | |
| Pfizer INC. | $16.28 | 2019 | |
| Antares Pharma, INC. | $15.62 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $13.86 | 2019 | |
| Circassia INC. | $12.82 | 2019 | |
| Mayne Pharma Commercial LLC | $11.71 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $10.00 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Parke listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.